 Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totaling 38,300 shares,  a growth of 307.4% from the September 30th total of 9,400 shares. Based on an average trading volume of 29,600 shares, the days-to-cover ratio is presently 1.3 days. Currently, 4.1% of the company’s stock are short sold. Currently, 4.1% of the company’s stock are short sold. Based on an average trading volume of 29,600 shares, the days-to-cover ratio is presently 1.3 days.
Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totaling 38,300 shares,  a growth of 307.4% from the September 30th total of 9,400 shares. Based on an average trading volume of 29,600 shares, the days-to-cover ratio is presently 1.3 days. Currently, 4.1% of the company’s stock are short sold. Currently, 4.1% of the company’s stock are short sold. Based on an average trading volume of 29,600 shares, the days-to-cover ratio is presently 1.3 days. 
Mannatech Price Performance
MTEX opened at $8.70 on Friday. The stock has a market capitalization of $16.54 million, a P/E ratio of -4.26 and a beta of 0.81. The company’s 50-day simple moving average is $8.92 and its two-hundred day simple moving average is $9.25. Mannatech has a 52-week low of $7.46 and a 52-week high of $16.49. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.49 and a current ratio of 1.11.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($2.27) earnings per share for the quarter. The company had revenue of $25.68 million for the quarter. Mannatech had a negative net margin of 3.46% and a negative return on equity of 48.60%.
Analyst Ratings Changes
Check Out Our Latest Research Report on Mannatech
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Articles
- Five stocks we like better than Mannatech
- Overbought Stocks Explained: Should You Trade Them?
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- What Are Some of the Best Large-Cap Stocks to Buy?
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- 3 Warren Buffett Stocks to Buy Now
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.

 
						 
						 
						 
						 
						